Radiomics-Based Artificial Intelligence Differentiation of Neurodegenerative Diseases with Reference to the Volumetry.
Eva-Yi-Wah CheungAnson C M ChauFuk Hay Tangnull On Behalf Of The Alzheimer's Disease Neuroimaging InitiativePublished in: Life (Basel, Switzerland) (2022)
This study showed that the radiomics features from T1-weighted MR images achieved excellence performance in differentiating AD, MCI and CN. Compared to the volumetry method, the accuracy, sensitivity and specificity are slightly lower in using radiomics, but still attained very good and reliable classification of the three stages of neurodegenerations. In view of the convenience and operator independence in feature extraction, radiomics can be a quantitative biomarker to differentiate the disease groups.